AGIOHealthcareMid-Cap
AGIOS PHARMACEUTICALS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for AGIOS PHARMACEUTICALS, INC. (AGIO), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are AGIO insiders buying or selling?
AGIOS PHARMACEUTICALS, INC. insiders reported 6 open-market buys ($128.1M) and 174 sells ($71.9M) across 180 Form 4 filings — a net buying position of $56.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 2, 2026)
Total Form 4 filings
180
SEC EDGAR
Insider filers
19
Insider buys (6)
$128.1M
Insider sells (174)
$71.9M
Insider sentiment
Net buyingNet insider flow of $56.2M in net buying.
Recent AGIO insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Sarah Gheuens | Chief Medical Officer | Sale | 4.0K | $37.56 | $150.5K |
| Apr 6, 2026 | James William Burns | Chief Legal Officer | Sale | 3.3K | $34.71 | $113.8K |
| Apr 6, 2026 | Sarah Gheuens | Chief Medical Officer | Sale | 2.9K | $34.71 | $102.0K |
| Apr 6, 2026 | Cecilia Jones | Chief Financial Officer | Sale | 3.1K | $34.71 | $109.0K |
| Apr 6, 2026 | Tsveta Milanova | Chief Commercial Officer | Sale | 3.3K | $34.71 | $113.2K |
| Apr 6, 2026 | Krishnan Viswanadhan | Chief Corp Dev & Strategy | Sale | 3.0K | $34.71 | $102.7K |
| Apr 6, 2026 | Brian Goff | Chief Executive Officer | Sale | 19.1K | $34.71 | $661.9K |
| Mar 9, 2026 | Krishnan Viswanadhan | Chief Corp Dev & Strategy | Sale | 3.0K | $27.80 | $82.3K |
| Mar 3, 2026 | Brian Goff | Chief Executive Officer | Sale | 18.1K | $28.96 | $522.9K |
| Mar 3, 2026 | James William Burns | Chief Legal Officer | Sale | 5.2K | $28.96 | $151.1K |
| Mar 3, 2026 | Sarah Gheuens | Chief Medical Officer | Sale | 4.1K | $28.96 | $117.4K |
| Mar 3, 2026 | Cecilia Jones | Chief Financial Officer | Sale | 5.0K | $28.96 | $145.8K |
| Mar 3, 2026 | Tsveta Milanova | Chief Commercial Officer | Sale | 2.9K | $28.96 | $83.1K |
| Mar 3, 2026 | Theodore James Washburn Jr. | Principal Accounting Officer | Sale | 2.2K | $28.96 | $64.4K |
| Jan 7, 2026 | Tsveta Milanova | Chief Commercial Officer | Sale | 2.9K | $27.02 | $77.6K |
| Jan 3, 2026 | James William Burns | Chief Legal Officer | Sale | 2.9K | $27.09 | $79.4K |
| Jan 3, 2026 | Brian Goff | Chief Executive Officer | Sale | 18.7K | $27.09 | $506.7K |
| Jan 3, 2026 | Sarah Gheuens | Chief Medical Officer | Sale | 2.9K | $27.09 | $79.4K |
| Jan 3, 2026 | Tsveta Milanova | Chief Commercial Officer | Sale | 2.9K | $27.09 | $79.4K |
| Jan 3, 2026 | Cecilia Jones | Chief Financial Officer | Sale | 2.9K | $27.09 | $79.4K |
| Nov 14, 2025 | David Scadden | Director | Sale | 200 | $43.84 | $8.8K |
| Nov 13, 2025 | Sarah Gheuens | Chief Medical Officer | Sale | 2.5K | $43.78 | $107.4K |
| Nov 3, 2025 | Sarah Gheuens | Chief Medical Officer | Sale | 200 | $43.81 | $8.8K |
| Oct 29, 2025 | Sarah Gheuens | Chief Medical Officer | Sale | 3.3K | $43.92 | $145.0K |
| Oct 10, 2025 | David Scadden | Director | Sale | 200 | $41.00 | $8.2K |
Showing the 25 most recent of 180 Form 4 filings for AGIOS PHARMACEUTICALS, INC..
Most active AGIO insiders
- David P Schenkein21 filings
- Christopher Bowden20 filings
- Theodore James Washburn Jr.18 filings
- Sarah Gheuens16 filings
- Scott Biller15 filings
Ask anything about AGIO insider activity
Use Trabud's AI agent to query AGIOS PHARMACEUTICALS, INC.'s Form 4 history in plain English — "Show me AGIO CEO purchases this year" or compare it against any other ticker.
Open the AI agentAGIO insider trading FAQ
Are AGIOS PHARMACEUTICALS, INC. insiders buying or selling?
Across 180 SEC Form 4 filings, AGIOS PHARMACEUTICALS, INC. (AGIO) insiders reported 6 open-market purchases totaling $128.1M and 174 sales totaling $71.9M. That is a net buying position of $56.2M.
How many insiders trade AGIO stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AGIOS PHARMACEUTICALS, INC.. The most recent filing was accepted on Jul 2, 2026.
Where does Trabud get AGIO insider trading data?
All AGIO insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.